Facial Nerve Electrode Array for Spontaneous Paralysis Recovery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for permanent facial paralysis are invasive, lengthy, and often ineffective, providing only minimal and non-spontaneous movement, requiring specialized surgeons and resulting in substantial healthcare costs and patient burden.
Innovation Solution
A method involving the implantation of an array of electrodes on targeted nerves and muscles, allowing for selective stimulation through electrical pulses to generate isolated movements, using a device that can be implanted in the facial nerve and synchronized with contractions from the healthy side of the face to achieve dynamic and spontaneous facial symmetry.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If free tissue microvascular transfer surgery is performed to treat facial paralysis, then some facial movement function is restored, but the surgical time is extremely long (6-12 hours) and requires general anesthesia
Solution Approach 1:
The patent extracts only the essential neural stimulation function from the complex free tissue transfer procedure. By implanting electrodes directly onto the facial nerve and connecting them to a pulse generator, the invention eliminates the need for lengthy microvascular anastomosis while achieving functional restoration through electrical stimulation of the nerve.
Solution Approach 2:
The patent replaces the mechanical biological system of free tissue transfer and nerve regeneration (which takes 6-12 hours and months respectively) with an electrical stimulation system. The electrode array directly stimulates the facial nerve to produce muscle contraction, substituting the slow biological regeneration process with immediate electrical activation.
2Reliability
If free tissue microvascular transfer surgery is performed, then facial movement is restored, but the procedure requires highly-specialized training and expert familiarity with surgical anatomy
Solution Approach 1:
The patent segments the complex free tissue transfer procedure into separate functional components: nerve identification, electrode placement, and pulse generation. This segmentation allows each component to be performed with standard surgical techniques rather than requiring expert-level microvascular anastomosis skills, making the procedure more accessible to general surgeons.
Solution Approach 2:
The patent creates a universal treatment approach that can be applied to various types of facial nerve injuries without requiring specialized free tissue transfer expertise. The electrode array and pulse generator system serves multiple functions (stimulation, monitoring, adjustment) that were previously distributed across multiple specialized surgical procedures.
3Reliability
If free tissue microvascular transfer surgery is performed, then some facial movement is achieved, but the movement is non-spontaneous and limited to about 8 millimeters of oral commissure excursion
Solution Approach 1:
The patent implements dynamic facial movement through programmable pulse generation. The pulse generator can adjust stimulation parameters (frequency, amplitude, pulse width) to produce natural-looking facial expressions that respond voluntarily to patient intent. This dynamic control enables full range of motion rather than the fixed 8mm excursion achieved by free tissue transfer.
Solution Approach 2:
The patent incorporates feedback mechanisms where the pulse generator responds to physiological signals or patient input to adjust stimulation patterns. This feedback loop enables spontaneous, natural facial movements that adapt to the patient's emotional state and intent, rather than the mechanical, non-spontaneous movement produced by transferred tissue.
4Reliability
If free tissue microvascular transfer surgery is performed, then facial function is partially restored, but the nerve must slowly grow into the graft taking 6-18 months for results to emerge
Solution Approach 1:
The patent performs preliminary action by directly stimulating the facial nerve with electrodes immediately after surgery. Rather than waiting for nerve regeneration to occur over 6-18 months, the electrical stimulation activates the nerve and muscle directly, producing functional movement from the outset. This preliminary activation maintains muscle tone and prevents atrophy while the nerve heals.
Solution Approach 2:
The patent substitutes the slow biological nerve regeneration process (6-18 months) with immediate electrical stimulation. The electrical current directly depolarizes nerve membranes and triggers muscle contraction without requiring axonal growth across the injury site, achieving functional restoration immediately rather than after prolonged regeneration.
5Reliability
If free tissue microvascular transfer surgery is performed, then facial movement is restored, but in about 10% of patients the muscle graft does not survive requiring return to operating room
Solution Approach 1:
The patent extracts the vulnerable transferred muscle graft from the treatment protocol and replaces it with direct neural stimulation. By stimulating the nerve in situ rather than transferring muscle tissue, the invention eliminates the risk of graft failure, vascular complications, and the need for return surgery to remove necrotic tissue.
Solution Approach 2:
The patent uses a disposable electrode array that can be easily replaced if needed, rather than relying on permanent transferred tissue that may fail. The electrodes are simple, replaceable components that do not carry the biological risks of free tissue transfer, including graft rejection, vascular thrombosis, and infection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables immediate and effective restoration of facial function with reduced surgical time, costs, and risks, allowing patients to achieve near-complete dynamic and spontaneous facial symmetry without the need for lengthy surgeries or extensive post-operative care.
Implementation Method 1
selectively stimulating the one or more targeted nerves and/or targeted muscles through electrical pulses delivered from the array
Data Source
AI summary
Disclosed herein is a method of treating a disease, comprising: (a) implanting an array of electrodes on one or more targeted nerves and/or targeted muscles; and (b) treating the disease by selectively stimulating the one or more targeted nerves and/or targeted muscles through electrical pulses delivered from the array. Also disclosed herein is a device, comprising a plurality of electrodes that have the capacity to be inserted in a facial nerve. Further disclosed herein is a method of treating facial paralysis and/or damage in a subject, comprising: (a) detecting the level of contraction of individual muscles on a healthy, non-paralyzed side of the face of the subject; and (b) treating facial paralysis by a direct targeted stimulation of the corresponding muscles or nerve fibers on a paralyzed side of the face of the subject. Also disclosed herein is a method of treating synkinesis, comprising: (a) implanting an array of electrodes on one or more targeted nerves and/or targeted muscles; and (b) selectively suppressing the one or more targeted nerves and/or targeted muscles through electrical pulses delivered from the array.